Form: SB-2/A

Optional form for registration of securities to be sold to the public by small business issuers

August 29, 2007


Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors
Novelos Therapeutics, Inc.

 
We consent to the use of our report dated March 19, 2007 in the Registration Statement No. 333-143263 of Novelos Therapeutics, Inc. on Form SB-2 (Amendment No. 3), relating to the registration of 12,000,000 shares of common stock. We also consent to the use of our name and the reference to us in the ‘‘Experts’’ section of this registration statement.
 
       
/s/ Stowe & Degon      
   
Worcester, MA
August 29, 2007
     
 
1